Form 4 for OCUL OCULAR THERAPEUTIX, INC
Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-30 · accession 0001104659-23-009410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-01 | 2023-01-30 | OCUL | Mattessich Antony C. | Pres, CEO, Dir | A - Grant | $0.00 | +176.3K | 465.9K | +61% | $0 |
| D | 2023-02-01 | 2023-01-30 | OCUL | Mattessich Antony C. | Pres, CEO, Dir | A - Grant | $0.00 | +536.9K | 536.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-30 | A | A | 176,300 | $0.00 | 465,950 | D | — | — | (F1) On January 30, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter. (F2) Includes 363,050 shares of common stock of the Company underlying unvested RSUs. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-01-30 | A | A | 536,900 | $0.00 | 536,900 | D | $3.88 · — to 2033-01-29 | 536,900 Common Stock | (F3) Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. |